MCKESSON CORP

McKesson (MCK) trades near its 52‑week high, up 14.97 % month‑to‑date, with a bullish trend above the 200‑day SMA—potential upside as pharma tech and supply‑chain AI grow.

McKesson Corp (MCK) dips 0.31% to $1,012.34, stays above its 200‑day SMA and near a 52‑week high, as health‑care distribution and digital‑analytics growth keep investors interested.

McKesson stock climbs 13.98% to $1,030.12, with market cap $117.6B and key metrics like a 200‑day SMA of $854.92 – learn why investors favor this pharma distributor.